Skip to main content
Equibles

Woodline Partners LP

Position in SYRE — Spyre Therapeutics, Inc.

CIK 1784547 San Francisco, CA
Back to SYRE Full portfolio

Position in SYRE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$27,171,030
+$13,759,438 QoQ
Shares Held
306,049
+15.1% QoQ
Ownership
0.347%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#47
of 266 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SYRE Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. SYRE ranks #46 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 2,002,863 $375,096,182
2 PTGX
Protagonist Therapeutics, Inc
 1,414,173 $173,349,326
3 TNGX
Tango Therapeutics, Inc.
 4,000,567 $125,057,724
4 BHVN
Biohaven Ltd.
 7,660,280 $113,984,966
5 COGT
Cogent Biosciences, Inc.
 2,603,162 $100,742,369
6 CYTK
Cytokinetics Inc
 1,100,708 $93,769,314
7 RCUS
Arcus Biosciences, Inc.
 3,007,798 $92,730,412
8 ROIV
Roivant Sciences Ltd.
 2,500,673 $88,498,817

All Filings in SYRE

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $27,171,030 306,049
2026-03-31 $13,411,592 265,892
2025-12-31 $8,710,621 265,892
2025-09-30 $2,210,241 131,876
2025-06-30 $6,963,325 465,152
2025-03-31 $7,499,677 464,808
2024-12-31 $8,210,390 352,680
2024-09-30 $7,771,768 264,256
2024-06-30 $6,174,102 262,616
2024-03-31 $3,812,989 100,527